Cargando…

IA方案和HAD方案诱导治疗FLT3-ITD突变阳性急性髓系白血病疗效比较

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial office of Chinese Journal of Hematology 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7343015/
https://www.ncbi.nlm.nih.gov/pubmed/31104447
http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2019.04.013
_version_ 1783555669277802496
collection PubMed
description
format Online
Article
Text
id pubmed-7343015
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Editorial office of Chinese Journal of Hematology
record_format MEDLINE/PubMed
spelling pubmed-73430152020-07-16 IA方案和HAD方案诱导治疗FLT3-ITD突变阳性急性髓系白血病疗效比较 Zhonghua Xue Ye Xue Za Zhi 短篇论著 Editorial office of Chinese Journal of Hematology 2019-04 /pmc/articles/PMC7343015/ /pubmed/31104447 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2019.04.013 Text en 2019年版权归中华医学会所有 http://creativecommons.org/licenses/by-nc-sa/3.0/ This work is licensed under a Creative Commons Attribution 3.0 License (CC-BY-NC). The Copyright own by Publisher. Without authorization, shall not reprint, except this publication article, shall not use this publication format design. Unless otherwise stated, all articles published in this journal do not represent the views of the Chinese Medical Association or the editorial board of this journal.
spellingShingle 短篇论著
IA方案和HAD方案诱导治疗FLT3-ITD突变阳性急性髓系白血病疗效比较
title IA方案和HAD方案诱导治疗FLT3-ITD突变阳性急性髓系白血病疗效比较
title_full IA方案和HAD方案诱导治疗FLT3-ITD突变阳性急性髓系白血病疗效比较
title_fullStr IA方案和HAD方案诱导治疗FLT3-ITD突变阳性急性髓系白血病疗效比较
title_full_unstemmed IA方案和HAD方案诱导治疗FLT3-ITD突变阳性急性髓系白血病疗效比较
title_short IA方案和HAD方案诱导治疗FLT3-ITD突变阳性急性髓系白血病疗效比较
title_sort ia方案和had方案诱导治疗flt3-itd突变阳性急性髓系白血病疗效比较
topic 短篇论著
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7343015/
https://www.ncbi.nlm.nih.gov/pubmed/31104447
http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2019.04.013
work_keys_str_mv AT iafāngànhéhadfāngànyòudǎozhìliáoflt3itdtūbiànyángxìngjíxìngsuǐxìbáixuèbìngliáoxiàobǐjiào
AT iafāngànhéhadfāngànyòudǎozhìliáoflt3itdtūbiànyángxìngjíxìngsuǐxìbáixuèbìngliáoxiàobǐjiào
AT iafāngànhéhadfāngànyòudǎozhìliáoflt3itdtūbiànyángxìngjíxìngsuǐxìbáixuèbìngliáoxiàobǐjiào
AT iafāngànhéhadfāngànyòudǎozhìliáoflt3itdtūbiànyángxìngjíxìngsuǐxìbáixuèbìngliáoxiàobǐjiào
AT iafāngànhéhadfāngànyòudǎozhìliáoflt3itdtūbiànyángxìngjíxìngsuǐxìbáixuèbìngliáoxiàobǐjiào
AT iafāngànhéhadfāngànyòudǎozhìliáoflt3itdtūbiànyángxìngjíxìngsuǐxìbáixuèbìngliáoxiàobǐjiào